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Low-cost shotgun DNA sequencing is transforming the microbial sciences. Sequencing
instruments are so effective that sample preparation is now the key limiting factor. Here,
we introduce a microﬂuidic sample preparation platform that integrates the key steps in cells
to sequence library sample preparation for up to 96 samples and reduces DNA input
requirements 100-fold while maintaining or improving data quality. The general-purpose
microarchitecture we demonstrate supports workﬂows with arbitrary numbers of reaction
and clean-up or capture steps. By reducing the sample quantity requirements, we enabled
low-input (B10,000 cells) whole-genome shotgun (WGS) sequencing of Mycobacterium
tuberculosis and soil micro-colonies with superior results. We also leveraged the
enhanced throughput to sequence B400 clinical Pseudomonas aeruginosa libraries and
demonstrate excellent single-nucleotide polymorphism detection performance that explained
phenotypically observed antibiotic resistance. Fully-integrated lab-on-chip sample preparation
overcomes technical barriers to enable broader deployment of genomics across many basic
research and translational applications.
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L
ow-cost DNA sequence data generation is enabling the
widespread application of genomic methods across the
microbial sciences. Genome sequencing can comprehen-
sively survey commensal microbiota1, enable the diagnosis of
drug resistant infections2–6 and reveal networks through which
infections are transmitted7. In particular, pathogen surveillance
by whole-genome shotgun (WGS) analysis provides information
for molecular epidemiology of critical value to public health7,8
that cannot be obtained by culture or PCR. To this point, a recent
Executive Order9 called for nationwide tracking of antibiotic
resistance in microbial pathogens by genome sequencing in the
US. In addition, natural products produced by microbes continue
to serve as a rich source of therapeutic compounds spanning
antibiotics to cancer10. Such compounds can be discovered by
performing large-scale sequencing of environmental samples11.
Despite impressive progress in technology for sequence data
production, the methods used to prepare sequencing samples lag
behind (Supplementary Fig. 1). To sequence bacterial genomes,
cells must be lysed and their DNA puriﬁed, fragmented, tagged
with adaptors and size-selected before loading on a sequencing
instrument. The complex experimental logistics and labour cur-
rently required to complete these steps limit sample throughput.
The introduction of liquid handling robotics and electrowetting-
based ‘digital’ microﬂuidics have helped to increase throughput,
but these workﬂows require high DNA input, do not integrate all
the key workﬂow steps (variously omitting cell lysis, DNA
fragmentation and size selection), and substantially offset
reductions in reagent and labour costs with expensive proprietary
equipment and consumables (Supplementary Fig. 2)12.
The performance of available sample preparation methods on
low-quantity samples is limiting in many microbial applications,
as microbes can be difﬁcult to isolate and grow to the quantities
required for sequencing. Data from samples that are expanded by
extensive culture or biochemical ampliﬁcation can be signiﬁcantly
biased and are more likely to be contaminated13–15. Available
library construction techniques typically require inputs of 41
million cell equivalents and are susceptible to contamination
(particularly at low-input levels)16–18.
Whole-genome sequencing holds promise as a low-cost,
rapid, essentially universal diagnostic for infectious disease19–21.
However, input quantity requirements present a serious barrier
for rapid WGS-based diagnostics for slow-growing microbes like
Mycobacterium tuberculosis. Applications in environmental
microbiology and natural product discovery are even further
restricted by high-input requirements since only about 1% of
environmental microbial isolates are easily cultured to produce a
large quantity of pure genomic material22. Innovations in
environmental sampling and culturing such as the iChip22
enhance the chance of producing novel isolates, but also produce
micro-colonies that are recalcitrant to scale-up culture and provide
too little biomass for available direct WGS approaches.
Here we introduce a new poly dimethylsulfoxide (PDMS)
microﬂuidic circuit architecture that integrates all the major steps
in sample preparation for the ﬁrst time (Supplementary Fig. 2;
Supplementary Data 1) and makes major advances in input
requirement and throughput while maintaining data quality. We
demonstrated the new microarchitecture for sample preparation
from clinical pathogen and environmental isolates, showing
excellent data quality at extraordinarily low-input quantities.
We expect this sample preparation platform will ﬁnd wide
application in a variety of high sample throughput genomics
applications2–5,23–26.
Results
Microdevice design and operation. Microﬂuidics is a natural
solution to increase throughput and reduce input requirements
thanks to its scalable automation and capability to precisely
manipulate small volumes27,28. Even small bench-top sequencing
instruments like the MiSeq can sequence many microbial
genomes per run, necessitating larger sample preparation batch
sizes. Thus, we optimized a high-density two-layer microﬂuidic27
sample-processing microarchitecture that enables a batch size up
to 96 samples per device run (Fig. 1 and Supplementary Fig. 3).
Integrating all the key WGS sample preparation steps in our
automated microﬂuidic device resulted in increased throughput,
reduced reagent consumption, reduced input requirements,
reduced contamination and improved reproducibility.
To prepare samples for genome sequencing, DNA must ﬁrst be
extracted from cells and then processed into properly sized
fragments with attached sequencing adaptors. We extract
genomic DNA in the device by lysing cells with a combination
of heat, detergents, and hydrolytic enzymes. To fragment and
attach adaptors to the gDNA, we apply the ‘tagmentation’
chemistry23–26,29, which uses transposase enzymes to insert
adaptor oligonucleotide sequences directly into high molecular
weight DNA. For DNA puriﬁcation, which is required at multiple
points in the sample preparation process, we implement the solid
phase reversible immobilization (SPRI)30 method in the
microﬂuidic system (Supplementary Note 1).
As we increased the reactor density to ﬁt 96 channels in a
70mm 35mm device, we adapted our design to prevent cross
contamination among samples and reagents, while still allowing
for a single shared waste stream and individual collection of
products.
Our microﬂuidic circuit performs the DNA extraction and
library construction steps in a rotary reactor31 of 36 nanoliters
(nl) that metres and mixes reagents and operates in concert with
ﬁlter valves to strain cells or beads from solution (Fig. 1a and
Supplementary Fig. 4). Standard micro-valves partition the rotary
reactor for dead-end-ﬁll loading27 of precise quantities of each
reagent. These same valves are used coordinately as peristaltic
pumps to mix reaction components within the rotary reactors
(Supplementary Fig. 3a). Filter valves are improved sieve valves27
that can be actuated to rapidly strain particles from solution
(Supplementary Fig. 5). To concentrate cells or purify,
concentrate, and size-select nucleic acid products, we capture
beads using ﬁlter valves at the output of each reactor
(Supplementary Fig. 3a). This puriﬁcation approach requires no
chemical modiﬁcation of the device32 and simpliﬁes the reaction
circuit since the ﬁlter valves can be directed to collect or release
beads by ﬂow in either direction, eliminating the need for
additional bypass channels that reduce reactor density33. The
micro-automated SPRI puriﬁcations used in DNA extraction,
reaction clean-up and size selection operations yield 480%
recovery of picogram-level starting material (Supplementary
Fig. 3b).
To establish multiple manifolds for solution loading/unloading
in the two-layer high-density format, we strategically placed waste
port ‘vias’ within each ﬁlter unit that connect to a ‘sewer line’ in
the bottom layer of the device33 (Supplementary Fig. 3a). This
arrangement enables bead, sample and reagent wastes to
escape the high-density reaction circuits in the device upper
layer without cross contamination (Supplementary Fig. 6;
Supplementary Note 2) and without the complexity of extra
device layers or extra space needed for internal access ports34. We
initially load reagents into each reactor through one manifold
(red arrow, Fig. 1a), while cells or gDNA samples are loaded via
individual input/output ports (black arrow, Fig. 1a).
Finally, the re-use of each rotary reactor for multiple process
steps eliminates the need for a series of reactors matched to
each workﬂow step. Re-use is enabled by the capability for
reaction/pull-down (for example, ﬁltration or puriﬁcation) steps.
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The combination of reactor re-use for an arbitrary number of
process steps together with pull-down/puriﬁcation capability
makes the system largely protocol-independent since most
next-generation sequencing (NGS) and cell-handling processes
can be accomplished with some number of these elementary steps
in combination.
Low-input DNA extraction and library construction. The
extraction and library construction workﬂow uses each reactor for
ﬁve different reaction steps (lysis, 2DNA precipitation, tag-
mentation and reaction stop) and the ﬁlter unit for three different
capture steps (cell capture and 2 SPRI bead capture). Low
sample input capability requires high efﬁciency lysis, puriﬁcation
and tagmentation, as well as contamination resistance to prevent
small samples from being overwhelmed by extraneous DNA.
We validated our microﬂuidic platform by processing four dif-
ferent low-input samples; samples of B1,000 E. coli cells,
B10,000 M. tuberculosis cells, B10,000 cell soil micro-colony
samples, and GC-rich genomic DNA samples from clinical
P. aeruginosa isolates (Supplementary Data 2).
The microﬂuidic devices consistently converted 5–15% of input
gDNA into library molecules as estimated by qPCR measurement
of output tagmentation products (Supplementary Fig. 3c). This
value is signiﬁcantly higher than previously reported low-input
library construction efﬁciencies of 0.5–2% (ref. 35). Efﬁciency
estimates derived from the duplicate sequence read rate agreed
with our qPCR analysis36 (Supplementary Note 3). Libraries
constructed on-chip from 50–100 picograms gDNA input showed
reproducible mapping rates, fragment sizes and insert sizes,
and k-mer frequencies consistent with standard high-input
sample preparation (Fig. 1c, Supplementary Figs 3d and 7)37.
On-device cell lysis and DNA extraction steps were also found
to be highly efﬁcient. We measured 10% end-to-end conversion
efﬁciency and found good library quality when using an ultra-low
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Figure 1 | Genomic sample preparation device operation and performance. (a) A photograph of the 96 36 nl microﬂuidic sample preparation device
ﬁlled with food colouring to highlight features. Dime indicates scale (white bar indicates 1 cm). Inset: the reactor (red), ﬁlter (yellow) and reservoir (green)
units. Black and red arrows designate reagent input ports and sample input/output ports, respectively. (b) The microﬂuidic sample preparation workﬂows
for biomass input (extreme left) and gDNA input (top). (c–e) Estimated sequence library complexity (units of fold-coverage) and mapping rate for (c) the
clinical P. aeruginosa isolate gDNA samples mapped to PA-14 (of the 384 samples, eight individual replicates were lost completely during the barcoding
step, leaving two replicates for each of these isolates. We know that these PCR drop-outs occurred due to faulty primers because these particular eight
primer sets were subsequently observed to fail consistently across multiple samples). (d) Low-input E. coli biomass samples mapped to BL21-DE3 and (e)
low-input M. tuberculosis biomass samples mapped to OFXR-14. (f) Comparison of microﬂuidic and optimized bench-top sample preparation from low-input
from soil micro-colony biomass (left, library complexity; right, human contamination). The library complexities were calculated using Picard tools (http://
broadinstitute.github.io/picard/) and the human DNA read fraction was determined using deconseq (http://deconseq.sourceforge.net/).
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input of just 1,000 E. coli cells, representing sample and reagent
inputs 200 times lower than standard ‘low input’ protocols that
specify 1 ng input (Fig. 1d; Supplementary Note 3). High
efﬁciency was also achieved for organisms like M. tuberculosis
(10,000 cell input) and environmental micro-colonies that are
known to be more challenging to lyse (Fig. 1e,f; Supplementary
Note 4).
To test how contamination and sequence library quality
compare at low input to conventional sample preparation, we
carried out a matched comparison of environmental micro-
colony sequence libraries prepared by the microﬂuidic method
with those prepared on the bench-top by an optimized low-input
procedure using the same reagents in the same laboratory
environment by the same operator (Supplementary Note 5).
For this comparison, we used soil samples from a private
Boston garden grown using the iChip22 system, which cultures
environmental microbes in situ to produce micro-colonies
(Supplementary Fig. 8). We estimated the iChip micro-colonies
to contain on the order of 100,000 cells each in total, and the
input for sample preparation to be on the order of 10,000 cells
(Supplementary Note 4). Each sample was split in half. One part
was directly loaded and processed in our device (Fig. 1b and
Supplementary Fig. 9), while the remaining portion was
processed using an equivalent sample-processing technique at
the bench-top. Comparing data from the two sample preparation
methods produced from the same micro-colonies in the same
HiSeq 2500 sequencing run, the on-device sample preparation
yielded an average of twice the library complexity, half the
coefﬁcient of variation in complexity, no drop-outs and far lower
human DNA contamination (Fig. 1f).
High-throughput library construction from clinical isolates.
To test the potential for our approach to address the sample-
processing bottleneck that limits application of microbial WGS
analysis, we applied our system to process libraries from 124P.
aeruginosa clinical isolates obtained from six randomly selected
subjects from Brigham and Women’s Hospital (Boston, MA).
A total of 12 to 24P. aeruginosa colonies were isolated from each
subject sample (Fig. 2a; Supplementary Data 3). To empirically
determine the single-nucleotide polymorphism (SNP) false
detection rate, colonies from two of the six subjects (P03 and P04)
were each sampled from ‘control’ plates representing expansions
of individual primary colonies. We extracted genomic DNA from
each culture, normalized the DNA concentrations and loaded the
samples into our microﬂuidic device for library construction.
To enable analysis of any errors that occurred during
sample preparation, sequencing or analysis38, we prepared
triplicate technical replicate libraries from each DNA sample
(Supplementary Note 6). A single pool of 384 barcoded
P. aeruginosa and control libraries was sequenced across two
HiSeq 2500 lanes (Supplementary Note 7 and 8).
Low-input libraries support high-speciﬁcation SNP calling. In
order to determine the genomic diversity across isolates and
reliably detect sequence variants with important functional
consequences like antibiotic resistance, sequencing libraries must
not introduce systematic errors and maintain uniform genomic
coverage. To compare our microﬂuidic Pseudomonas libraries to
those produced using bench-top methods, we instantiated an
informatics pipeline for SNP calling (Supplementary Fig. 10)
with an allelic fraction (AF) threshold as the primary adjustable
parameter controlling sensitivity and speciﬁcity (Supplementary
Fig. 11). We deﬁne the AF as the fraction of quality-adjusted39
variant base counts at a given reference position. A lower AF
threshold increases SNP calling sensitivity but increases false-
positive calls arising from errors that might occur in library
construction, sequencing and read mapping operations.
We found that setting the AF threshold to 0.82 limited the
number of discordant SNPs detected across replicate libraries to
zero (using discordant SNPs as a heuristic for erroneous variant
calls38; Fig. 2b,c). To benchmark our parameterized pipeline,
we analysed data from a previous study of SNPs in clinical
Burkholderia dolosa isolates40 and successfully detected all the
reported SNPs (Supplementary Data 4).
To validate the actual sensitivity and speciﬁcity of SNP calls in
analysis of low-input microﬂuidic sequence libraries versus
bench-top libraries, we prepared several libraries from the same
isolate sample: three low-input (50 pg) microﬂuidic libraries and
three high-input (24 ng) bench-top libraries, each sequenced to
50 coverage; and an additional high-input ‘gold standard’
bench-top library sequenced to 340 coverage. At 50 mean
coverage of the 50 pg microﬂuidic libraries, no false-positive SNPs
were detected versus the 340 high-input library, indicating that
accuracy was better than 1.4 10 7 when calling more than 99%
of reference positions. At equal mean coverage, there was no
signiﬁcant decrease in the quality of SNP calls made from the
picogram-input libraries produced in our device versus the
nanogram-input bench-top libraries (Fig. 2d). In fact, the 50
low-input consensus base calling accuracy from the 50 pg input
samples compares favourably to that reported for advanced
single-strand consensus sequencing approaches that depend on
extraordinarily deep sequence coverage and extra sample
preparation steps (10 5; ref. 41). Although we expect replicate
library sequencing to suppress rare sample preparation artifacts
like PCR errors, our comparison revealed no signiﬁcant difference
in the accuracy of replicate library sequencing compared with
single-library sequencing at equivalent depth in our samples
(Fig. 2d), indicating that artifacts from library construction
affected variant calling at a frequency below 10 7.
Comparative genomics of clinical Pseudomonas isolates. In
examining sequence variation between isolates, we identiﬁed
25,000–90,000 SNP sites across isolates from different subjects
(Fig. 2e), but isolates from the same subject were essentially clonal
(Fig. 2f; Supplementary Data 5). We detected no SNP sites among
three subjects’ isolates (P01, P02 and P06) and one of the control
plates (P03). Among isolates from subject P05, just two SNP sites
were identiﬁed, and only one SNP site was identiﬁed among
isolates from control plate P04, with 2 of 24 isolates showing
evidence for the same variant at this locus (Supplementary
Note 9). Because the variant base in these two samples was
reproducibly detected across the technical replicates in both
affected subject P04 isolates (six sequence libraries in total),
we can exclude sample preparation and sequencing errors as
explanations for the variant calls. Rather, these calls likely arose
from a mixture of strains being transferred to the control plate
from overlapping colonies on the primary plate or a mutation
that occurred during subsequent laboratory culture.
Our antibiotic resistance phenotype testing and gene content
analysis likewise showed homogeneity across isolates from a given
subject and extensive differences between isolates from different
subjects (Fig. 3a and Supplementary Fig. 12; Supplementary
Note 10). The core genes that were common in isolates
between subjects were enriched for function in central dogma
processes, while genes that varied between subjects were enriched
for functions related to DNA transposition, recombination,
restriction-modiﬁcation, and transition metal response genes tied
to mercury resistance (Supplementary Fig. 13; Supplementary
Data 6 and 7; Supplementary Note 11). To fully validate the small
number of variant calls made among the patient-speciﬁc isolate
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populations, the no-calls we made at loci with metrics near our
analysis thresholds (Supplementary Fig. 14; Supplementary
Data 5; Supplementary Note 9), and the variants responsible
for drug resistance (described below), we performed Sanger
sequencing, ﬁnding agreement with the short-read analysis in all
cases.
WGS sequencing accurately predicts antibiotic resistance.
Our sequence analysis of the clinical Pseudomonas isolates
identiﬁed variant bases known to confer resistance to imipenem,
ciproﬂoxacin and ceftazidime, three antibiotics commonly used to
treat pulmonary P. aeruginosa infections (Fig. 3a; Supplementary
Data 8). All 24 isolates from subjects P01 and P04 had a
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Figure 2 | Pseudomonas aeruginosa clinical isolate sequencing and error correction. (a) Four types of samples were collected from six different subjects;
(1) bronchial alveolar lavage, (2) sputum, (3) thoracostomy and (4) urine. Samples were streaked on primary plates and two control plates, which are
expanded from single colonies. (b) Concordant SNP call sets are deﬁned as call sets that agree among all technical replicate libraries. (c) The fraction of
concordant and discordant SNPs among technical replicates (n¼ 3) of one isolate from each subject (P01-4, P02-26, P03-58, P04-72, P05-105 and P06-
115, where the notation P01-4 means patient subject 1, sample 4) is plotted with decreasing AF stringency (minimum read depth ﬁxed at 6; minimum
mapping quality ﬁxed at 45; excluding indels; see ‘Methods’ section). Inset: thresholding at an AF value of 0.82 (circles) balances the maximization of
concordant SNPs and minimization of discordant SNPs and was used for variant calling across all our samples. (d) Receiver operator characteristic (ROC)
plot compares the accuracy and sensitivity in SNP calling among low-input libraries of sample P01-4 made in the device, on the bench-top libraries from
individual replicates, from pooled triplicate replicates, and at different average coverage levels. With the AF threshold value at 0.82 (red circles), there is no
meaningful difference between microﬂuidic and bench-top libraries, or between single replicate and pooled triplicates at equal coverage. Due to differences
in gene content and genomic structure of the reference and the subject P01 strain, 7% of the reference genome had no coverage in this analysis and 1.9% of
the remaining sequence was masked due to poor average read mapping quality (MQo45; Supplementary Note 9). (e) Homology tree constructed based
on the number of inter-subject SNPs. (f) Heat map of SNPs between each sample, grouped by the patient subject. Asterisks indicate control plate isolates
that were expanded from single colonies. Numbers represent median number of SNPs in each subject pair block.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms13919 ARTICLE
NATURE COMMUNICATIONS | 8:13919 | DOI: 10.1038/ncomms13919 | www.nature.com/naturecommunications 5
non-synonymous SNP, V126E, in the mexR (efﬂux pump)
gene consistent with previously reported imipenem resistance
mutations42. Similarly, all isolates from subjects P01 and P03 had
two SNPs, T83I in the gyrA (gyrase A) gene and S87L in the parC
(topoisomerase IV) gene, each reported to yield ciproﬂoxacin
resistance43. All 12 isolates from subject P06 had a ciproﬂoxacin
resistance mutation, S466Y in the gyrB44 (gyrase B) gene, that
was not found in the other subjects. In our drug resistance
phenotype test45 (Fig. 3a; Supplementary Note 10), 100% of the
phenotypically observed variability in resistance was explained by
our low input, high-throughput WGS data (Fig. 3a).
Direct de novo WGS analysis of soil micro-colonies. Our
microﬂuidic platform showed data performance equal to bench-
top library construction methods with orders of magnitude less
input, lending the conﬁdence to carry out strain and natural
product prediction from the iChip micro-colony samples. We
de novo assembled the genome of each micro-colony data set
produced as described above (Supplementary Data 9) and
phylotyped the micro-colonies at the strain level using a
multi-locus sequence typing analysis46.
Of the 14 colonies analysed, 12 represented ﬁve different
known Pseudomonas strains (P. sp GM74, P. sp GM78, P. sp
GM16, P. fragi B25 and P. chlororaphis GP72). We identiﬁed the
remaining two colonies as Serratia proteamaculans S4 and
Varivorax sp. CF313, respectively (Fig. 3b and Supplementary
Fig. 15). Our high-GC Pseudomonas assemblies, based on low-
input sample-processing direct from cells, were more contiguous
than recently reported draft environmental Pseudomonas
assemblies produced from sequence libraries prepared by
standard, high-input methods47 (Supplementary Data 9). The
device was also more reliable in producing libraries from our
micro-colony samples, as two of the bench-top libraries dropped
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Figure 3 | Functional genomics from low-input microbial samples. (a) Antibiotic susceptibility phenotyping and genotyping. Antibiotic susceptibility was
tested on a randomly sampled subset of isolates from each subject by the disc diffusion susceptibility assay. The drugs tested are IPM, CIP and CAZ (10 mg
imipenem, 5 mg ciproﬂoxacin and 30mg ceftazidime, respectively). Raw images of one plate from each subject that was analysed (left). Plot shows inhibition
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the Clinical & Laboratory Standards Institute (CLSI) break point (red line) indicate samples that are resistant to the speciﬁc antibiotic (grey points). Radii
greater than the green line indicates samples identiﬁed as susceptible by the CLSI break point (blue points). The ﬁrst ten samples from subject P05 were
measured on a separate day from the remaining P05 samples; the apparent difference in susceptibility in these samples and the remaining P05 samples is
most likely due to a systematic difference in the assay (possibly image contrast) on the second day or degradation of the drug sample used between the
two measurement sets (we classify all the P05 isolates tested as susceptible to ciproﬂoxacin). (b) Phylotyping of the soil micro-colonies and (c) secondary
metabolite class prediction using AntiSMASH analysis of de novo assembled genomic contigs. The clustering of samples in the phylotyping results is
reﬂected in the secondary metabolite predictions. The red numbers in (b) indicate the number of SNPs between the strains spanning each value. The heat
map values in (c) represent empirical similarity scores11.
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out entirely during the sample preparation process (Fig. 1f and
Supplementary Fig. 16) and six of the fourteen bench-top libraries
were at or below a library complexity of 200 genomic equivalents,
the minimum required to enable 50 unique coverage with
acceptable read duplication rate.
Soil samples are frequently mined for natural products,
recently yielding teixobactin, a promising agent under develop-
ment for treating Gram-positive bacterial infections48. We
analysed our micro-colony draft genomes for natural product
genes using the anti-SMASH tool11 (Fig. 3c). While the
metabolite-producing gene cluster proﬁles between the device
libraries and bench-top libraries mostly agreed (except where the
bench-top samples dropped out entirely), the Serratia and
Varivorax samples gave divergent results, with the higher-
quality microﬂuidic libraries likely producing more accurate
gene calls (Supplementary Fig. 16).
Discussion
Despite the ability of Illumina’s HiSeq and NextSeq platforms
to process hundreds of microbial sequence libraries per run,
genomic analysis is underutilized in epidemiology, clinical care
and natural product discovery due to the complexity, limited
throughput, labour-intensity, and input quantity requirements of
available sample preparation methods. Here, we piloted an
automated microﬂuidic system that integrates at high throughput
all the key steps in NGS sample preparation: cell concentration,
lysis, fragmentation, adaptor tagging, fragment puriﬁcation and
size selection (Supplementary Fig. 2; Supplementary Data 2,
10 and 11). By lowering input requirements 200-fold, our
system also enables new applications such as rapid analysis of
slow-growing pathogen isolates and direct analyses of samples
with limited biomass.
We constructed nearly 400 WGS sequence libraries from 124
isolates of P. aeruginosa collected from six patients. Our analysis
revealed tremendous inter-subject diversity in gene content and
genome sequence even though all six samples were collected from
the same hospital within a period of a few weeks. Despite the
dynamic accessory genome known in Pseudomonas, we found
negligible intra-subject variation in our samples, indicating that
the infected sites contained essentially clonal Pseudomonas
populations, not the diverse Pseudomonas populations often
described in the chronic pulmonary infections common among
cystic ﬁbrosis patients (Supplementary Note 12). The population
signature we observed is consistent with community-acquired
infection or infection of these patients from their own microbiota
in the hospital setting.
The genomic determinants of imipenem and ciproﬂoxacin
resistance were apparent in our variant calls and concordant with
phenotypic susceptibility assays. We also found substantial gene
content and sequence variation across strains with the same
multiple resistance phenotype, indicating that these strains most
likely acquired resistance to the same set of drugs independently.
As is often found in Pseudomonas, we noticed diversity in the
gene content across the isolates from different patients, notably
enrichment of DNA integration and restriction functions in the
variable genome that may be related to horizontal gene transfer,
subject-speciﬁc prophage (Supplementary Figs 17 and 18) and
other putatively exogenous sequences (Supplementary Fig. 19;
Supplementary Data 12; Supplementary Note 13), as well as
mercury resistance elements, which have previously been linked
to the development of antibiotic resistance49,50.
These analyses were enabled by the Q68þ SNP calling
performance achieved by the tuned variant caller38. Replicate
sequencing that enabled this performance increases the need
for automation of sample preparation and low-input sample
preparation, but has the power to discriminate sequencing errors
from errors introduced during library construction including base
damage, PCR-derived mutations, and chimeras.
We demonstrated that the microﬂuidic system’s integrated
DNA extraction capability works at very low-input levels for
challenging sample types like M. tuberculosis cells and soil
micro-colonies. This eliminates the need for pre-ampliﬁcation
by whole-genome ampliﬁcation, which increases workﬂow
complexity and degrades data quality. The input reduction to
thousands of cells could cut diagnostic test times in half for
slow-growing pathogens like M. tuberculosis. Lowering input
requirements also enables new organism and natural product
discovery by direct WGS analysis of environmental microbes that
are hard to culture, such as the iChip micro-colonies. Side-by-side
comparison of soil micro-colony WGS analysis with an optimized
bench-top procedure makes clear the superior performance of the
new microﬂuidic method in reliability and critical data metrics.
Future synthetic biology approaches51 to synthesize natural
product genes for expression in industrial production strains
would place even higher demands on sequence and assembly
quality. Re-discovery of known natural products is a limiting
factor in the discovery of novel bioactive compounds52, placing a
premium on isolating the most challenging-to-grow organisms
that are enriched in diversity versus known microbes.
We expect the increased automation, throughput and
low-input capability of our microﬂuidic library construction
method to enable a wide variety of future applications. Current
library preparation protocols require nanograms to micrograms
of DNA that have been previously extracted from cells. Some
protocols require that DNA be pre-fragmented and size-selected
in addition. Eliminating such challenging input requirements
could expand the use of less invasive but low-yield sampling and
biopsy procedures, enable direct pathogen identiﬁcation in tiny
microbiome samples, better enrichment of cell types or tissue
regions of interest in clinical micro-samples, and eliminate
whole-genome pre-ampliﬁcation from some workﬂows53. The
high throughput and high accuracy sample preparation method
presented here will power applications including precision
medicine, genomic surveillance, antibiotic resistance tracking2–5
and novel organism/natural product discovery on large scales.
Methods
Microﬂuidic device fabrication. Microﬂuidic devices were fabricated by multi-
layer soft lithography of PDMS, a transparent silicone elastomer, on a mould
comprised of a silicon wafer patterned with photoresist. Mould and device
fabrication were carried out at the Broad Institute. Separate moulds were used to
cast a control layer of height 50 mm and a ﬂow layer of height 6mm. The two layers
were partially cured, aligned manually and thermally bonded by further curing.
Inlet ports were punched and the two-layer PDMS device was bonded to a glass
slide after activation by air plasma exposure.
The ﬂow layer mould was patterned in ﬁve steps: (1) rectangular 15 mm,
(2) rectangular 5 mm, (3) rounded 15 mm, (4) rectangular 30 mm and (5) rectangular
100 mm features. The rectangular features were made by spin coating SU-8 2001
(5 mm), 2015 (15 and 30 mm) and 2050 (100 mm) photoresists (Microchem) on a
silicon wafer. The coated wafers were patterned by ultraviolet exposure (OAI 206
mask aligner) through a mask printed at 20,000 dpi (Fineline; see Autocad design
ﬁles for each layer in supplementary material), followed by feature development in
SU-8 developer (Microchem). The rounded features were produced by spin coating
AZ-4620 photoresist (Microchem) after coating with Hexamethyldisilazane
(Sigma) and air-drying, patterning the wafer with UV exposure and a mask,
developing in the AZ 400K developer (Microchem), and slowly heating (from 65 C
to 190 C over 4 h) the wafer above the resist Tg (120 C) to round the features.
The control layer mould was patterned in two steps: (1) rectangular 15 mm and
(2) rectangular 90 mm features, using methods similar to those for the ﬂow layer.
Device production utilized standard soft lithography protocols. PDMS
(Momentive) was mixed at 5:1 silicone to cross-linker ratio in a Thinky AR250
mixer, poured onto the ﬂow layer mould, degassed in a vacuum chamber and cured
by baking for 1 h at 80 C. PDMS at a 20:1 silicone to cross-linker ratio was spin
coated on the valve layer mould to a height of 50 mm, then baked at 80 C for
40min. The two layers were aligned under a stereomicroscope (Nikon), and further
baked for 2 h at 80 C to complete thermal bonding. Inlet holes were punched into
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the two-layered PDMS device (Syneo, ID 660mm tips) on the designated
input/output port features. The device was then exposed to atmospheric plasma for
30 s at a pressure of 1.3 mbar (Diener ATTO), bonded to a clean glass slide and
baked for 3 h at 80 C.
Device design ﬁle and controller. Flow and control layers were pneumatically
activated by an array of 40 solenoid valves (Pneumadyne) controlled by a USB
interface (McMaster) connected to a computer. The device controller was home-
built following designs and procedures speciﬁed by Dr Rafael Go´mez-Sjo¨berg
and the Prof. Stephen Quake group at Stanford University as described at:
https://sites.google.com/site/rafaelsmicroﬂuidicspage/valve-controllers/usb-based-
controller.
The valve operation pressure was 40 PSI and sample/reagent solutions were
driven at 20 PSI.
The device CAD ﬁle is publicly available on: https://sourceforge.net/projects/
sk-dev-cad-analysis-software/ﬁles/Kim_supplementaryﬁles.zip /download.
Clinical P. aeruginosa isolate sample collection and culture. The clinical
samples used in this study were discards from the Brigham and Women’s Hospital
microbiology lab, and were disconnected from patient meta-data. Samples from
selected sites of infection were streaked on selective media plates containing
MacConkey agar. 12 to 24 P. aeruginosa colonies were identiﬁed by appearance
and randomly picked (Fig. 2a). P. aeruginosa isolates were received at the Broad
Institute as frozen liquid cultures. They were grown to mid-log phase at a
concentration of 5 108 cellsml 1 in lysogeny broth (LB). Culture density was
monitored by OD600 using a UV–vis spectrophotometer.
DNA extraction from clinical isolates (bench-top method). DNA was puriﬁed
from bacterial cultures using Qiagen DNeasy Blood and Tissue kits on the
QIAcube instrument (Qiagen). The cell input was between one and two million
cells per sample. After extraction, the concentration of puriﬁed gDNA was
measured by absorption at 260 nm (Nanodrop) and normalized to 20 ng ml.
M. tuberculosis culture. Two M. tuberculosis clinical isolates (OFXR14 and
OFXR16) were grown in Middlebrook 7H9 medium supplemented with OADC
(Becton Dickinson), 0.05% Tween 80 (Sigma) and 0.2% glycerol at 37C with
shaking. Samples were taken at OD600 0.05 to 0.1, which corresponds to
B1.5–3 107 bacterial cells per ml. A 100ml culture sample from each isolate was
heat inactivated at 80 C for 2 h, ﬂash frozen and used for all analyses.
iChip soil bacteria culture. A 1 g sample of soil collected from a private garden in
Boston, MA was agitated vigorously for 10min in 10ml sterile phosphate buffered
saline (PBS). The soil was left to settle for 5min and the supernatant was diluted
again in PBS. Dilutions were then mixed with molten agar media (0.1 g starch, 1.0 g
casamino acids, 15 g technical agar per 1 l of H2O). The soil suspension was diluted
further with agar to achieve an average concentration of one cell per 100 ml. Then
100ml of the soil-agar suspension was dispensed into the each well of an iChip22,
which had a 0.03 mm polycarbonate membrane attached to the bottom via silicone
glue. After the agar suspension was solid, a 0.03 mm polycarbonate membrane was
attached to the top of the iChip using silicone glue. The iChip was incubated in
direct contact with moist soil in the dark for 2 weeks. After 2 weeks, iChips were
disassembled and individual colonies were picked with sterile toothpicks using a
dissection microscope, and placed into 15 ml PBS for further analysis.
Tagmentation (bench-top method, 24 ng input). Bench-top library construction
was done following the Illumina Nextera protocol for tagmentation. 5 ml of
4.8 ng ml 1 (24 ng total) of puriﬁed gDNA was mixed with 15 ml of Nextera
enzyme (Illumina), 5 ml of 5 Tagmentation buffer (50mM Tris-HCl pH 8.0
(Sigma), 20mM MgCl2 (Sigma)) and 10ml of H2O, then incubated for 10min at
58 C. 2.5 ml of stop solution (2.5% wt per vol SDS (Sigma) in H2O) was added to
the mixture, followed by incubation for 10min at 72 C. Tagmented DNA
was puriﬁed by mixing with 49.5 ml SPRI bead suspension (Beckman-Coulter),
binding for 10min at 25 C, magnetically separating the beads, washing twice
with ethanol and eluting the product off the beads with 50 ml of 10mM Tris-HCl
pH 8.0.
Commercial DNA extraction method (bench-top bead beating). We attempted
using the MoBio Power-soil kit (Qiagen) with 7 ml of cells (B104 total cells) to
extract gDNA for library construction but did not obtain a sufﬁcient quantity of
tagmented DNA fragments after library construction (o1 picograms of ampliﬁable
tagmented product; data not shown).
Library quantiﬁcation (qPCR). Before enrichment PCR, an aliquot from each
library produced on the device was quantiﬁed by qPCR to verify successful library
construction. qPCR was performed by mixing 1 ml of tagmented product with 0.5 ml
Eva green dye (Evrogen), 0.5 ml of Rox reference dye (ROCHE), 0.5 ml of N12
Nextera barcoding primer (Illumina), 0.5 ml of E502 Nextera barcoding primer
(Illumina), 4 ml of DNA polymerase ready mix (Illumina) and 3 ml of H2O, then
performing qPCR in a real-time thermocycler (Stratagene MX3005p). The thermal
programme was: 5min at 72 C, 1min at 95 C, then 40 cycles of (1) 10 s at 95 C,
(2) 30 s at 60 C and (3) 30 s at 72 C. To quantify the properly adapted tagmented
library molecules in each sample the qPCR ampliﬁcation curve of each sample was
compared with the curves resulting from analysis of puriﬁed standards (ampliﬁed,
size-selected library) of similar average molecular weight and GC content. The
reference libraries were quantiﬁed using the Qubit method (ThermoFisher) and
Kapa library quantiﬁcation kits (Kapa Biosystems).
Enrichment/barcoding PCR and sample pooling. The sequencing libraries
created on the microﬂuidic devices were barcoded using the Broad Institute’s
dual barcoding primers (Broad Genomics Platform), for which validation was not
yet complete. Eight libraries were lost in the enrichment PCR step from the
Pseuodomonas set due to bad primers.
4 ml of each tagmented sample library (B5 pg) was mixed with 0.5 ml of
primer 1, 0.5 ml of primer 2, 4 ml of ampliﬁcation mix (Illumina) and 1 ml of
H2O. Our libraries were ampliﬁed by 15 cycles of PCR (optimized for 5 pg input),
SPRI puriﬁed and Qubit quantiﬁed. The libraries were then pooled into a
single mix in equal concentrations based on their Qubit-measured concentrations.
DNA sequencing. Quality assessment runs (library construction efﬁciency,
sensitivity versus speciﬁcity, k-mer abundance and fragment size distribution) and
production runs of test libraries were carried out by sequencing across variably
conﬁgured Illumina MiSeq runs (2 50, 2 75, 2 150, 2 250 and 2 300). The
quality assessed samples were sequenced on the Illumina Hiseq 2500 platform
(2 125 cycles or 2 101 cycles) in the Broad Genomics Platform.
Antibiotic susceptibility testing. Clinical Pseudomonas aeruginosa isolates were
grown to mid-log phase in Luria broth (LB), and 100ml of each culture was spread
on an LB agar plate and allowed to dry for 15min face-up at room temperature.
Disks impregnated with ceftazidime (30 mg, Becton Dickinson), ciproﬂoxacin (5 mg,
Becton Dickinson) or imipenem (10 mg, Becton Dickinson) were placed at evenly
spaced distances on these plates, which were then incubated for 16 h at 37 C.
Plates were imaged using a FluorChem FC2 system (Alpha-Innotech) set to the
visible range, and the radius of the zone of inhibition around each disk was
measured using a custom Matlab image analysis script. These radii were compared
with standards determined by the Clinical Laboratory Standards Institute (CLSI).
The breakpoints for each antibiotic are as follow (S and R stand for susceptible and
resistant, respectively):
(1) Ciproﬂoxacin: S421mm; Ro15mm
(2) Imipenem: S416mm; Ro13mm
(3) Ceftazidime: S418mm; Ro14mm
Analysis software and commands. Software and commands used for sequencing
analysis are available in the supplementary methods. Custom analysis software is
publicly available on https://sourceforge.net/projects/sk-dev-cad-analysis-software/
ﬁles/Kim_supplementaryﬁles.zip/download.
Data availability. Primary accessions. National Center for Biotechnology
Information (NCBI) Sequence Read Archive (SRA)
clinical P. aeruginosa raw reads fastq PRJNA295070
clinical P. aeruginosa de novo assemblies fasta PRJNA295070
low-input E. coli raw reads fastq PRJNA295070
M. tuberculosis raw reads fastq PRJNA295070
soil micro-colonies raw reads fastq PRJNA295070
Referenced accessions. NCBI Reference sequence
Pseudomonas aeruginosa UCBPP-PA14 complete genome NC_008463.1
Mycobacterium tuberculosis OFXR-14 scaffold GCF_000660185.1
Mycobacterium tuberculosis OFXR-16 scaffold GCF_000660225.1
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